Literature DB >> 27604733

Experimental Models Combining TBI, Hemorrhagic Shock, and Hypoxemia.

Lai Yee Leung1, Ying Deng-Bryant2, Deborah Shear2, Frank Tortella2.   

Abstract

Animal models of traumatic brain injury (TBI) provide important tools for studying the pathobiology of brain trauma and for evaluating therapeutic or diagnostic targets. Incorporation of additional insults such as hemorrhagic shock (HS) and/or hypoxemia (HX) into these models more closely recreates clinical scenarios as TBI often occurs in conjunction with these systemic insults (i.e., polytrauma). We have developed a rat model of polytrauma that combines penetrating TBI, HS and HX. Following brain trauma, HX was induced by reducing the inspired oxygen while HS was induced by withdrawing blood to lower the mean arterial pressure. The physiological, histological, and behavioral aspects of this animal model have been characterized and have demonstrated exacerbating effects of systemic insults on penetrating TBI. As such, this model may facilitate the use of simultaneous assessments of multiple mechanisms and provide a platform for testing novel diagnostic and therapeutic targets.

Entities:  

Keywords:  Additional insults; Blood loss; Combined neurotrauma; Hemorrhagic shock; Hypoxemia; Polytrauma; Respiratory distress; Traumatic brain injury

Mesh:

Year:  2016        PMID: 27604733     DOI: 10.1007/978-1-4939-3816-2_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Outcomes after concomitant traumatic brain injury and hemorrhagic shock: A secondary analysis from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios trial.

Authors:  Samuel M Galvagno; Erin E Fox; Savitri N Appana; Sarah Baraniuk; Patrick L Bosarge; Eileen M Bulger; Rachel A Callcut; Bryan A Cotton; Michael Goodman; Kenji Inaba; Terence O'Keeffe; Martin A Schreiber; Charles E Wade; Thomas M Scalea; John B Holcomb; Deborah M Stein
Journal:  J Trauma Acute Care Surg       Date:  2017-06-06       Impact factor: 3.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.